Showing results (1191-1200 of 2,458) with videos related to

Sort By:
Pageof 246
Therapie|April 3, 2023
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022Kevin Bihan, Lorène Lipszyc, Florian Lemaitre, et al.
Therapie|July 27, 2025
[Managing benzodiazepine withdrawal using prazepam substitution: Retrospective study of 86 patients]Amir Kallab Debbih, Christophe Cutarella, Elisabeth Jouve, et al.
Therapie|August 20, 2025
A new tool to study the effects of in utero medication exposure on neurodevelopment in childrenLaurane Delteil, Caroline Hurault-Delarue, Catherine Arnaud, et al.
Therapie|June 21, 2025
[Early non-compliance with oral anticancer drugs, a clinical pharmacy as key issue in onco-senology]Fanny Leenhardt, Pauline Ares, Alma Nicolai, et al.
Therapie|July 6, 2024
[Balancing drug regulation and health democracy: The role of patient and healthcare professional advisors at the ANSM]Patrick Maison, Trystan Bacon, Pascale Daynes, et al.
Therapie|February 6, 2024
[Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic]Zineb Ghrieb, Anouk Walter-Petrich, Jin Huang, et al.
Therapie|January 21, 2024
[Misuse of paracetamol in primary care: Cross-sectional study in a French rural context]Shérazade Kinouani, Claire Vielle, Céline Lambert, et al.
Therapie|August 27, 2024
[Use of a pharmaceutical decision support system in the valuation of hospital stays: Evaluation through 3 examples in collaboration with the department of medical information]Laurine Robert, Ali Laraba, Amélie Bruandet, et al.
Therapie|October 25, 2024
Translation of the REMEDI[e]S (Review of potentially inappropriate MEDIcation pr[e]scribing in Seniors) explicit criteria into seminatural language for use in prescription support systems: A multidisciplinary consensusRomane Freppel, Anaïs Barbier, Mathilde Dambrine, et al.
Therapie|August 22, 2024
[Adverse effects of the tezacaftor/ivacaftor/elexacaftor combination that may lead to discontinuation: About a series of 10 cases]Elora Blaisonneau, Brendan Le Daré, Marion Mercerolle, et al.
Pageof 246